Lipoic Acid supplementation in AIDS patients has been shown to increase plasma ascorbic acid, glutathione, and
T-helper lymphocytes and T-helper/suppressor cell ratio in a significant number of patients. All of these factors are
important biomarkers in AIDS progression, suggesting that Lipoic Acid supplementation may help slow the
progression of HIV and AIDS. The daily dosage was 1,500 mg, three times daily.
Studies indicate that Lipoic Acid inhibits HIV replication by reducing the activity of reverse transcriptase (the
enzyme responsible for manufacturing the virus from the DNA of lymphocytes) and inhibits the activation in HIV that
leads to viral replication.10,11,12